Drug profile · INN
mebutamate
DORMATE
mebutamate (DORMATE) is a unknown. Route of administration: oral. Current US regulatory status: approved.
FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — mebutamate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
mebutamate (DORMATE) is a unknown. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN mebutamate
Brand DORMATE
Mechanism Unknown
Route ORAL
Formulation TABLET
Mechanism of action
Unknown
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Frequently asked questions
What is mebutamate?
mebutamate (DORMATE) is a unknown. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for mebutamate?
DORMATE is a marketed brand name for mebutamate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of mebutamate?
mebutamate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.